Shining a light on the COVID-19 vaccines

The road out of COVID-19

Shining a light on the COVID-19 vaccines

Will the road through 2021 see the new vaccines return our pre-pandemic lifestyles? There are certainly very positive signs that there is light at the end of the ‘COVID-19’ tunnel for Australians. So, which vaccines will be available and when?

 

It seems extraordinary that in under one year since the world faced this unprecedented pandemic, the first vaccines for COVID-19 are being administered. In Australia, the current timing for the initial vaccines is planned for March 2021. We have lived up to our title ‘the lucky country’ being relatively sheltered in our island home. Our eyes will be on the world stage where Australia will have the benefit of the data from the initial vaccine roll outs prior to our own program implementation.

The Australian Government has numerous vaccines in the pipeline for an Australian vaccination program:

Vaccine 1
Stage:
When:
Production:

University of Oxford/AstraZeneca vaccine
Phase 3 Clinical Trials
Planned availability early 2021
(contingent on Therapeutic Goods Association [TGA] approval)
October 2020, the TGA granted a provisional determination to AstraZeneza for this vaccine. It is eligible to apply for provisional registration on the Australian Register of Therapeutic Goods.

Planned manufacture by CSL in partnership with AstraZeneca
8 million doses will be delivered to Australia in early 2021
30 million doses will be manufactured in Australia from early 2021 through to September 2021 in monthly batches.

Vaccine 2
Stage:
When:

Production:

Novavax vaccine
Phase 3 Clinical Trials
Planned availability early 2021 (contingent on Therapeutic Goods Association [TGA] approval)

Phase 1/2 clinical trials are currently being conducted in Australia and the United States. Large-scale Phase 3 clinical trials are currently underway in the United Kingdom (UK) involving up to 15,000 volunteers. The vaccine is being tested in adults 18-84 years of age in different populations, people living with HIV, and those with other chronic conditions.”

Planned manufacture by CSL in partnership with AstraZeneca
40 million doses will be made available in Australia during 2021

Vaccine 3
Stage:
When:

Production:

Pfizer vaccine/BioNTech
Phase 3 Clinical Trials
Planned availability early 2021 (contingent on Therapeutic Goods Association [TGA] approval)

Pfizer is in production of this vaccine and initial vaccines initiated in UK December for emergency use, but it yet to be fully approved
10 million doses secured for importation to Australia once approved by the TGA
50 million vaccine doses expected in 2020 production
Up to 3 billion doses by the end of 2021

Planned manufacture by CSL in partnership with AstraZeneca

COVAX facility

As reported by the Australian Department of Health “The Australian Government has joined the COVAX Facility as part of a global effort to support rapid, fair and equitable access to COVID-19 vaccines. This participation enables us to purchase vaccine doses for Australia as they become available. Currently 188 countries around the world have entered into the COVAX Facility.”

It is further reported that our commitment to this facility secures over 25,000,000 doses of COVID-19 vaccines which would be enough for half of our population given the 2-dose requirement. There are currently ten vaccines candidates in this program, three of which are listed above.

University of Queensland/CSL vaccine has been abandoned due to false HIV positivity.

The incredible work and collaboration globally and within Australia have us well placed for a safe roll out of vaccinations through 2021.

No Comments

Post A Comment